Published in The British Pharmacological Society 3M tested the systemic pharmacodynamic effects of the salmeterol component of two pressurised metered dose inhalers that delivered a combination of salmeterol and fluticasone propionate (SM/FP).
The paper reports on the results of the safety equivalence study that was pivotal in the approval of a new SM/FP inhalation product.
